Randomized Phase II Study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)-Reference-Cited by-同舟云学术

Randomized Phase II Study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)

Published:2016-12 Issue:6 Volume:39 Page:609-613
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Lee Francis A.S.,Zee Benny Chung-Ying,Cheung Foon Yiu,Kwong Philip,Chiang Chi Leung,Leung Kwong Chuen,Siu Steven W.K.,Lee Conrad,Lai Maria,Kwok Chloe,Chong Marc,Jolivet Jacques,Tung Steward

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference16 articles.

1. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

2. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol,2009

3. Antisense therapy for cancer;Gleave;Nat Rev Cancer,2005

4. Antisense therapy for cancer—the time of truth;Jansen;Lancet Oncol,2002

5. Antisense therapy in cancer;Pawlak;Cancer Treat Rev,2000

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing cancer treatments: The role of oligonucleotide-based therapies in driving progress;Molecular Therapy - Nucleic Acids;2024-09

2. In silico and in vivo anti-angiogenic validation on ethanolic extract of Curcuma longa and curcumin compound in hepatocellular carcinoma through mitogen activated protein kinase expression in male and female wistar rats;Food and Chemical Toxicology;2023-12

3. Unlocking Synergistic Potential: Enhancing Regorafenib Efficacy in Hepatocellular Carcinoma Through Combination Therapy With 18β-Glycyrrhetinic Acid;Anticancer Research;2023-09-29

4. NVS-ZP7-4 inhibits hepatocellular carcinoma tumorigenesis and promotes apoptosis via PI3K/AKT signaling;Scientific Reports;2023-07-21

5. LenvatinibVersusSorafenib in Advanced Hepatic Cell Carcinoma: A Double Center Retrospective Analysis;Anticancer Research;2023-01-25